BRAZE INC-A
BRZENASDAQ🏆 #1598 by market capEarnings Sep 3US Equity
$27.68▼ $0.53 (−1.91%)
🌅 Pre-market$28.13▲ 1.63%Regular close · extended-hours price shown1h—
24h▼ 1.9%
7d▲ 7.7%
14d▲ 10.5%
30d▲ 5.7%
1y▲ 9.5%
🏦Market Cap
$3.12B
Small Cap
📈Revenue Growth (YoY)
+24.4%
Healthy
📊Gross Margin
66.5%
High
💵FCF Margin
8.4%
Moderate
⚖️P/S Ratio
4.0x
Fair
Otter Score
54
Weak
📊
Analyst Ratings
Price
$27.68
Total
25
Raised
1
Lowered
0
Avg PT
$32.80
H / L
$35 / $30
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Reiterated | Overweight | 2026-07-06 | — | — |
Citigroup | Reiterated | Buy | 2026-05-29 | $59.00 | +113.20% |
DA Davidson | Reiterated | Buy | 2026-05-28 | $33.00 | +19.20% |
Mizuho | Reiterated | Outperform | 2026-05-28 | — | — |
Citizens | Reiterated | Market Outperform | 2026-05-28 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-05-28 | $38.00 | +37.30% |
Piper Sandler | Reiterated | Overweight | 2026-05-28 | $30.00 | +8.40% |
Canaccord Genuity | Reiterated | Buy | 2026-05-28 | $35.00 | +26.40% |
BTIG | Reiterated | Buy | 2026-05-26 | $45.00 | +62.60% |
Oppenheimer | Reiterated | Outperform | 2026-03-25 | $40.00 | +44.50% |
Goldman Sachs | Reiterated | Buy | 2026-03-25 | $34.00 | +22.80% |
UBS | Reiterated | Buy | 2026-03-25 | $62.00 | +124.00% |
Stifel | Reiterated | Buy | 2026-03-25 | — | — |
Barclays | Reiterated | Overweight | 2026-03-25 | $45.00 | +62.60% |
Needham | Reiterated | Buy | 2026-03-25 | $50.00 | +80.60% |
TD Cowen | Reiterated | Buy | 2026-03-20 | — | — |
Wells Fargo | Reiterated | Overweight | 2025-12-10 | $45.00 | +62.60% |
JMP Securities | Reiterated | Market Outperform | 2025-09-05 | $52.00 | +87.90% |
Loop Capital | Reiterated | Buy | 2025-06-06 | — | — |
Stephens & Co. | Reiterated | Overweight | 2025-06-06 | — | — |
Raymond James | Reiterated | Outperform | 2025-06-06 | $50.00 | +80.60% |
Macquarie | Reiterated | Neutral | 2025-06-06 | $39.00 | +40.90% |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-03-28 | — | — |
Scotiabank | Upgraded | Sector Perform → Sector Outperform | 2024-07-10 | $56.00 | +102.30% |
Cowen & Co. | Reiterated | Outperform | 2022-09-13 | — | — |
Institution
JP Morgan
Reiterated · Overweight · 2026-07-06
—
—
Citigroup
Reiterated · Buy · 2026-05-29
$59.00
+113.20%
DA Davidson
Reiterated · Buy · 2026-05-28
$33.00
+19.20%
Mizuho
Reiterated · Outperform · 2026-05-28
—
—
Citizens
Reiterated · Market Outperform · 2026-05-28
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-05-28
$38.00
+37.30%
Piper Sandler
Reiterated · Overweight · 2026-05-28
$30.00
+8.40%
Canaccord Genuity
Reiterated · Buy · 2026-05-28
$35.00
+26.40%
BTIG
Reiterated · Buy · 2026-05-26
$45.00
+62.60%
Oppenheimer
Reiterated · Outperform · 2026-03-25
$40.00
+44.50%
Goldman Sachs
Reiterated · Buy · 2026-03-25
$34.00
+22.80%
UBS
Reiterated · Buy · 2026-03-25
$62.00
+124.00%
Stifel
Reiterated · Buy · 2026-03-25
—
—
Barclays
Reiterated · Overweight · 2026-03-25
$45.00
+62.60%
Needham
Reiterated · Buy · 2026-03-25
$50.00
+80.60%
TD Cowen
Reiterated · Buy · 2026-03-20
—
—
Wells Fargo
Reiterated · Overweight · 2025-12-10
$45.00
+62.60%
JMP Securities
Reiterated · Market Outperform · 2025-09-05
$52.00
+87.90%
Loop Capital
Reiterated · Buy · 2025-06-06
—
—
Stephens & Co.
Reiterated · Overweight · 2025-06-06
—
—
Raymond James
Reiterated · Outperform · 2025-06-06
$50.00
+80.60%
Macquarie
Reiterated · Neutral · 2025-06-06
$39.00
+40.90%
Citizens Capital Markets
Reiterated · Market Outperform · 2025-03-28
—
—
Scotiabank
Upgraded · Sector Perform → Sector Outperform · 2024-07-10
$56.00
+102.30%
Cowen & Co.
Reiterated · Outperform · 2022-09-13
—
—
One row per institution · price target from the firm's latest published target